17 studies were found.

1.		Recruiting	A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension Conditions: Glaucoma, Open-Angle; Ocular Hypertension
2.		Recruiting	A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT) Conditions: Glaucoma, Open-Angle; Ocular Hypertension
3.		Recruiting	An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD. Conditions: Macular Degeneration; Maculopathy, Age-Related
4.		Recruiting	An evaluation of safety and efficacy of Anecortave Acetate vs. placebo in patients with subfoveal choroidal neovascularization(CNV) due to wet age-related macular degeneration(AMD) Conditions: Macular Degeneration; Maculopathy, Age-Related; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related
5.		Recruiting	A long-term safety study of once-daily Travatan Conditions: Glaucoma, Open-Angle; Ocular Hypertension
6.		Recruiting	Mechanism of Action of TRAVATAN 0.004% in Subjects with Glaucoma or Ocular Hypertension Conditions: Glaucoma; Ocular Hypertension
7.		Recruiting	Open-Label Posterior Juxtacleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients with AMD Condition: Macular Degeneration
8.		Recruiting	Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-69 Conditions: Open-Angle Glaucoma; Ocular Hypertension
9.		Recruiting	Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-70 Conditions: Open-Angle Glaucoma; Ocular Hypertension
10.		Recruiting	Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-02-41 Conditions: Open-Angle Glaucoma; Ocular Hypertension
11.		Recruiting	Phase 4 study comparing IOP lowering in OAG or OH in Caucasian or Japanese subjects C-02-32 Conditions: Open-Angle Glaucoma; Ocular Hypertension
12.		Recruiting	Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients Conditions: Open-Angle Glaucoma; Ocular Hypertension
13.		Recruiting	Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes Conditions: Open-Angle Glaucoma; Ocular Hypertension
14.		Recruiting	Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients with Glaucoma or Ocular Hypertension Conditions: Glaucoma; Ocular Hypertension
15.		Recruiting	Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients with Glaucoma or Ocular Hypertension. Conditions: Glaucoma; Ocular Hypertension
16.		Recruiting	A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with chronic angle-closure glaucoma Conditions: Glaucoma, Angle-Closure; Ocular Hypertension
17.		Recruiting	A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with open-angle glaucoma(OAG) or ocular hypertension(OHT) Conditions: Glaucoma, Open-Angle; Ocular Hypertension